Tectonic Therapeutic To Present on May 15th, 2025 at the Bank of America Securities Health Care Conference
Tectonic Therapeutic (NASDAQ: TECX), a clinical stage biotech company specializing in therapeutic proteins and antibodies for GPCR modulation, has announced its participation in the Bank of America Securities 2025 Health Care Conference in Las Vegas. Dr. Alise Reicin, President and CEO, will deliver a corporate presentation on Thursday, May 15th, 2025, at 9:20am PDT.
The management team will be available for one-on-one meetings with investors during the conference. A live webcast will be accessible through the company's website, with a replay available for approximately 90 days after the event.
Tectonic Therapeutic (NASDAQ: TECX), un'azienda biotecnologica in fase clinica specializzata in proteine terapeutiche e anticorpi per la modulazione dei GPCR, ha annunciato la sua partecipazione alla Bank of America Securities 2025 Health Care Conference a Las Vegas. La Dott.ssa Alise Reicin, Presidente e CEO, terrà una presentazione aziendale il giovedì 15 maggio 2025 alle 9:20 PDT.
Il team di gestione sarà disponibile per incontri individuali con gli investitori durante la conferenza. Una diretta webcast sarà accessibile tramite il sito web dell'azienda, con la possibilità di rivedere la registrazione per circa 90 giorni dopo l'evento.
Tectonic Therapeutic (NASDAQ: TECX), una empresa biotecnológica en etapa clínica especializada en proteínas terapéuticas y anticuerpos para la modulación de GPCR, ha anunciado su participación en la Bank of America Securities 2025 Health Care Conference en Las Vegas. La Dra. Alise Reicin, Presidenta y CEO, ofrecerá una presentación corporativa el jueves 15 de mayo de 2025 a las 9:20 am PDT.
El equipo directivo estará disponible para reuniones individuales con inversores durante la conferencia. Habrá una transmisión en vivo accesible a través del sitio web de la empresa, con una repetición disponible durante aproximadamente 90 días después del evento.
Tectonic Therapeutic (NASDAQ: TECX)는 GPCR 조절을 위한 치료용 단백질 및 항체를 전문으로 하는 임상 단계의 생명공학 회사로, 라스베이거스에서 열리는 Bank of America Securities 2025 Health Care Conference에 참여한다고 발표했습니다. 알리스 레이신 박사(Alise Reicin) 사장 겸 CEO가 2025년 5월 15일 목요일 오전 9시 20분 PDT에 기업 프레젠테이션을 진행할 예정입니다.
경영진은 컨퍼런스 기간 동안 투자자들과 일대일 미팅을 진행할 예정입니다. 회사 웹사이트를 통해 라이브 웹캐스트가 제공되며, 행사 후 약 90일간 다시보기 서비스도 이용할 수 있습니다.
Tectonic Therapeutic (NASDAQ: TECX), une société biotechnologique en phase clinique spécialisée dans les protéines thérapeutiques et les anticorps pour la modulation des GPCR, a annoncé sa participation à la Bank of America Securities 2025 Health Care Conference à Las Vegas. La Dre Alise Reicin, Présidente et CEO, présentera une conférence d'entreprise le jeudi 15 mai 2025 à 9h20 PDT.
L'équipe de direction sera disponible pour des réunions individuelles avec les investisseurs durant la conférence. Une diffusion en direct sera accessible via le site web de la société, avec un replay disponible pendant environ 90 jours après l'événement.
Tectonic Therapeutic (NASDAQ: TECX), ein biotechnologisches Unternehmen in der klinischen Phase, das sich auf therapeutische Proteine und Antikörper zur GPCR-Modulation spezialisiert hat, gab seine Teilnahme an der Bank of America Securities 2025 Health Care Conference in Las Vegas bekannt. Dr. Alise Reicin, Präsidentin und CEO, wird am Donnerstag, den 15. Mai 2025, um 9:20 Uhr PDT eine Unternehmenspräsentation halten.
Das Management-Team steht während der Konferenz für Einzelgespräche mit Investoren zur Verfügung. Ein Live-Webcast wird über die Website des Unternehmens zugänglich sein, mit einer Wiederholung, die etwa 90 Tage nach der Veranstaltung verfügbar ist.
- None.
- None.
WATERTOWN, Mass., May 07, 2025 (GLOBE NEWSWIRE) -- Tectonic Therapeutic, Inc. (NASDAQ: TECX) (“Tectonic”), a clinical stage biotechnology company focused on the discovery and development of therapeutic proteins and antibodies that modulate the activity of G-protein coupled receptors (“GPCRs”), today announced that Alise Reicin, MD, President and Chief Executive Officer, will present at the Bank of America Securities 2025 Health Care Conference taking place in Las Vegas on May 12-15, 2025.
Bank of America Securities Health Care Conference
| Date: | Thursday, May 15th, 2025 |
| Time: | 9:20am PDT |
| Format: | Corporate Presentation |
| Presenter: | Alise Reicin, MD, President and Chief Executive Officer |
| Webcast: | Link |
The Tectonic management team will host one-on-one meetings at the conference. Interested investors should contact their Bank of America Securities representative to schedule meetings.
The live webcast can also be accessed under “Events & Presentations” on the Investors section of the Tectonic website at www.tectonictx.com. Once the conference has concluded, a replay of the webcast will be available on the Company’s website for approximately 90 days.
About Tectonic
Tectonic Therapeutic is a clinical-stage biotechnology company focused on the discovery and development of therapeutic proteins and antibodies that modulate the activity of GPCRs. Leveraging its proprietary technology platform called GEODe™ (GPCRs Engineered for Optimal Discovery), Tectonic is focused on developing biologic medicines that overcome the existing challenges of GPCR-targeted drug discovery and harness the human body to modify the course of disease. Tectonic focuses on areas of significant unmet medical need, often where therapeutic options are poor or nonexistent, as these are areas where new medicines have the potential to improve patient quality of life. Tectonic is headquartered in Watertown, Massachusetts. For more information, please visit www.tectonictx.com and follow us on LinkedIn.
Investors: Dan Ferry LifeSci Advisors daniel@lifesciadvisors.com (617) 430-7576 Media: Kathryn Morris The Yates Network kathryn@theyatesnetwork.com (914) 204-6412
FAQ
When is Tectonic Therapeutic (TECX) presenting at the Bank of America Securities Health Care Conference 2025?
Who will be presenting for Tectonic Therapeutic (TECX) at the Bank of America Healthcare Conference?
How can investors access Tectonic Therapeutic's (TECX) presentation at the Bank of America conference?
How can investors schedule one-on-one meetings with Tectonic Therapeutic (TECX) management?
